Dinalgen 150 mg/ml Solution for Injection for Cattle, Pigs and Horses 100ml.
-Reduction of inflammation and pain associated with post-partum, musculoskeletal disorders and lameness.
-Reduction of fever associated with bovine respiratory disease.
-Reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate.
-Reduction of pyrexia in cases of respiratory disease and Postpartum Dysglactia Syndrome-PDS-(Metritis Mastitis Agalactia syndrome) in sows, in combination with antimicrobial therapy, where appropriate.
-Reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders (lameness, laminitis, osteoarthritis, synovitis, tendinitis, etc.).
-Reduction of postoperative pain and inflammation.
-Reduction of visceral pain associated with colic.
Dosage and administration
For intravenous or intramuscular use.
Administer the product via the intravenous or intramuscular route, preferably in the neck region, at a dose of 3 mg of ketoprofen/kg bw/day, equivalent to 1 ml/50 kg bw/day of the product. The duration of treatment is 1-3 days, and should be established according to the severity and duration of symptoms.
Administer the product via the intramuscular route at a dose of 3 mg of ketoprofen/kg bw/day equivalent to 1 ml/50 kg bw/day of the product, on a single occasion. Depending on the response observed and based on the benefit-risk analysis by the responsible veterinarian treatment may be repeated at intervals of 24 hours for a maximum of three treatments. Each injection should be given at a different site.
Administer via the intravenous route at a dose of 2.2 mg of ketoprofen/kg bw/day, equivalent to 0.75 ml/50 kg bw/day of the product. The duration of treatment is 1-5 days, and should be established according to the severity and duration of symptoms. In the case of colic one injection is normally sufficient. A second administration of ketoprofen requires a clinical re-examination.
Use during pregnancy and lactation
Studies in laboratory animals (rats, mice, rabbits) and cattle have not produced any evidence of adverse effects. Can be used in pregnant cows.
The safety of the veterinary medicinal product has not been established during pregnancy in sows and mares. Use only accordingly to the benefit-risk assessment by the responsible veterinarian.
Can be used in lactating cows and sows.
The use is not recommended in lactating mares.
100ml amber type II glass vial, closed with bromobutyl rubber stoppers and flip-off aluminium caps.